MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Isolated micrographia following stroke

    P. Montero Escribano, M.J. Catalán Alonso, F. Alonso French, E. López Valdés, R. García Ramos, I. Parees Moreno (Madrid, Spain)

    Objective: We report a new case of isolated micrographia due to stroke involving the lenticular nucleus. Background: Micrographia is a common sign in Parkinson´s disease…
  • 2016 International Congress

    Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease

    V.V. Cozac, M. Chaturvedi, U. Gschwandtner, F. Hatz, A. Meyer, K. Nowak, R. Sturzenegger, P. Fuhr (Basel, Switzerland)

    Objective: To investigate whether changes in EEG power spectra could predict development of dementia in Parkinson's disease (PD-D). Background: Different research groups have reported, that…
  • 2016 International Congress

    Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

    P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)

    Objective: To determine the gray matter (GM) changes in different clinical stages of Parkinson's disease (PD) using Voxel Based Morphometry (VBM). Background: PD is a…
  • 2016 International Congress

    Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes

    C. Gaddipati, M. Umaiorubahan, C.U. Velmurugendran, V. Shankar (Chennai, India)

    Objective: We attempted to find an objective tool by assessing the variability of levodopa induced change in the blink reflex recovery to differentiate Parkinsonian syndromes.…
  • 2016 International Congress

    Modulation of local field potentials during gait in the STN of patients with Parkinson’s disease

    F. Hell, J.H. Mehrkens, A. Plate, K. Bötzel (München, Germany)

    Objective: PD patients with implanted DBS electrodes allow for the investigation of basal ganglia activity during gait. Background: Whereas the overall spectral content of local…
  • 2016 International Congress

    Multi-modal imaging in Parkinson’s disease patients with freezing of gait

    J.M. Hall, C. O'Callaghan, J.M. Shine, M. Gilat, C.C. Walton, K.A. Ehgoetz Martens, A.A. Moustafa, S.J.G. Lewis (Milperra, Australia)

    Objective: The objective of the current study is to refine understanding of the pathophysiological mechanisms underlying freezing of gait (FOG) in Parkinson's disease (PD) using…
  • 2016 International Congress

    The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease

    C.O. Souza, M.C. Voos, H.F. Chien, D.V. Francato, A.F. Barbosa, J.M. Greve, E.T. Fonoff, E.R. Barbosa (Sao Paulo, Brazil)

    Objective: The aim of this study was to verify if there would be correlations between cognitive variables (educational status, executive function, verbal fluency) and motor…
  • 2016 International Congress

    Mild cognitive impairment in Parkinson’s disease: Impact on caregiver outcomes

    J.Y.Y. Szeto, M. Gilat, C.C. Walton, L. Mowszowski, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

    Objective: To utilise the newly established the International Parkinson and Movement Disorder Society (MDS) Task Force diagnostic criteria for Mild Cognitive Impairment (MCI) in Parkinson's…
  • 2016 International Congress

    Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension

    K.E. McDonell, C.A. Shibao, I. Biagginoi, D. Robertson, D.O. Claassen (Nashville, TN, USA)

    Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…
  • 2016 International Congress

    Affective theory of mind in Parkinson’s disease

    A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

    Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…
  • « Previous Page
  • 1
  • …
  • 338
  • 339
  • 340
  • 341
  • 342
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley